Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Rasmusson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancers|January 21, 2023
Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection SamplesRokas Stulpinas, Dovile Zilenaite-Petrulaitiene, Allan Rasmusson, et al.
Biomed Research International|July 29, 2017
Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer TissueGedmante Radziuviene, Allan Rasmusson, Renaldas Augulis, et al.
The Journal of Surgical Research|December 9, 2023
Overall Survival Prediction by Tumor Microenvironment Lymphocyte Distribution in Hepatocellular Carcinoma After Liver TransplantationAiste Gulla, Rokas Stulpinas, Agne Grigonyte, et al.
Cancers|October 14, 2020
Immuno-Interface Score to Predict Outcome in Colorectal Cancer Independent of Microsatellite Instability StatusAusrine Nestarenkaite, Wakkas Fadhil, Allan Rasmusson, et al.
Frontiers in Oncology|July 3, 2020
Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast CarcinomaDovile Zilenaite, Allan Rasmusson, Renaldas Augulis, et al.
Cancers|January 11, 2024
Improving HCC Prognostic Models after Liver Resection by AI-Extracted Tissue Fiber Framework AnalyticsRokas Stulpinas, Mindaugas Morkunas, Allan Rasmusson, et al.
The American Journal of Pathology|March 21, 2020
Immunogradient Indicators for Antitumor Response Assessment by Automated Tumor-Stroma Interface Zone DetectionAllan Rasmusson, Dovile Zilenaite, Ausrine Nestarenkaite, et al.
Frontiers in Oncology|December 3, 2021
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer PatientsGedmante Radziuviene, Allan Rasmusson, Renaldas Augulis, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan CriteriaRokas Stulpinas, Ieva Jakiunaite, Agne Sidabraite, et al.
Human Pathology|April 3, 2026
Spatially-resolved CD8+ and CD34+ computational immunohistochemistry indicators improve post-nephrectomy risk stratification in clear cell renal cell carcinomaMantas Fabijonavicius, Ausra Garnelyte, Dovile Zilenaite-Petrulaitiene, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancers|January 21, 2023
Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection SamplesRokas Stulpinas, Dovile Zilenaite-Petrulaitiene, Allan Rasmusson, et al.
Biomed Research International|July 29, 2017
Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer TissueGedmante Radziuviene, Allan Rasmusson, Renaldas Augulis, et al.
The Journal of Surgical Research|December 9, 2023
Overall Survival Prediction by Tumor Microenvironment Lymphocyte Distribution in Hepatocellular Carcinoma After Liver TransplantationAiste Gulla, Rokas Stulpinas, Agne Grigonyte, et al.
Cancers|October 14, 2020
Immuno-Interface Score to Predict Outcome in Colorectal Cancer Independent of Microsatellite Instability StatusAusrine Nestarenkaite, Wakkas Fadhil, Allan Rasmusson, et al.
Frontiers in Oncology|July 3, 2020
Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast CarcinomaDovile Zilenaite, Allan Rasmusson, Renaldas Augulis, et al.
Cancers|January 11, 2024
Improving HCC Prognostic Models after Liver Resection by AI-Extracted Tissue Fiber Framework AnalyticsRokas Stulpinas, Mindaugas Morkunas, Allan Rasmusson, et al.
The American Journal of Pathology|March 21, 2020
Immunogradient Indicators for Antitumor Response Assessment by Automated Tumor-Stroma Interface Zone DetectionAllan Rasmusson, Dovile Zilenaite, Ausrine Nestarenkaite, et al.
Frontiers in Oncology|December 3, 2021
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer PatientsGedmante Radziuviene, Allan Rasmusson, Renaldas Augulis, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan CriteriaRokas Stulpinas, Ieva Jakiunaite, Agne Sidabraite, et al.
Human Pathology|April 3, 2026
Spatially-resolved CD8+ and CD34+ computational immunohistochemistry indicators improve post-nephrectomy risk stratification in clear cell renal cell carcinomaMantas Fabijonavicius, Ausra Garnelyte, Dovile Zilenaite-Petrulaitiene, et al.
Pageof 3